Osteoarthritis (OA) is the most common form of arthritis, affecting over 32 million Americans. According to the World Health ...

Samantha Bianzon explained what biology-guided radiation therapy for cancer is, as well as highlighted how it may differ from ...

Combining targeted radionuclide therapy and immunotherapy could improve melanoma survival. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2018 / 06 / 180625122549.htm ...

Targeted radionuclide therapy has been found to create a favorable tumor microenvironment in prostate cancer that improves the effectiveness of immunotherapies. The research, presented at the ...

By Dennis Thompson HealthDay ReporterMONDAY, July 7, 2025 (HealthDay News) — Radiation therapy to treat cancer might be a double-edged sword that increases the risk posed by other malignant tumors, a ...

This is the hope behind a radioactive molecule for targeted radionuclide therapy that has been developed at PSI and is now being tested in the clinic. "With our new radionuclide, we hope to be able to ...

A recent trial reveals that targeted stereotactic radiation significantly reduces neurologic death rates in small cell lung ...

Surgically Targeted Radiation Therapy can cut down on post operative office visits and also allow for less damage to healthy tissue. By Brian Duffy. Updated: Mar. 3, 2021 at 3:46 PM EST ...

Radiation therapy advancements, including SBRT and proton therapy, have improved precision and reduced side effects for GI cancer patients, enhancing their quality of life. Personalized treatment ...

Combination of alpha- and beta-radionuclide therapy is feasible, tolerable, and effective for colorectal cancer, according to preclinical research presented at the 2024 Society of Nuclear Medicine ...

The phase III Radiation Therapy Oncology Group (RTOG) 0522 study (Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer) ...

Sanofi is deepening its commitment to targeted radiation treatments for cancer with a €300 million equity investment in a new entity pursuing next-generation radioligand therapies.. The new ...